| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC COM | 32,500 | 473,000 | 0.04% | ||
| 2 | Ascendis Pharma | 35,540 | 617,000 | 0.06% | ||
| 3 | DERMIRA INC COM | 42,274 | 649,000 | 0.06% | ||
| 4 | ENTEROMEDICS INC | 811,760 | 743,000 | 0.07% | ||
| 5 | ROKA BIOSCIENCE INC | 250,000 | 800,000 | 0.07% | ||
| 6 | RAPTOR PHARMACEUTICAL CORP | 155,000 | 1,685,000 | 0.16% | ||
| 7 | ANTHERA PHARMACEUTICALS I | 425,000 | 1,900,000 | 0.18% | ||
| 8 | KINDRED BIOSCIENCES INC | 275,000 | 1,964,000 | 0.18% | ||
| 9 | TRIVASCULAR TECHNOLOGIES INC | 198,000 | 2,077,000 | 0.19% | ||
| 10 | INVITAE CORP | 125,000 | 2,095,000 | 0.20% | ||
| 11 | XENOPORT INC | 310,000 | 2,207,000 | 0.21% | ||
| 12 | PTC THERAPEUTICS INC | 40,500 | 2,464,000 | 0.23% | ||
| 13 | SPARK THERAPEUTICS INCORPORATED | 33,106 | 2,566,000 | 0.24% | ||
| 14 | CELLECTIS S A | 75,000 | 2,594,000 | 0.24% | ||
| 15 | BENEFITFOCUS INC | 75,000 | 2,759,000 | 0.26% | ||
| 16 | AVALANCHE BIOTECHNOLOGIES IN | 70,500 | 2,857,000 | 0.27% | ||
| 17 | INFINITY PHARMACEUTICALS INC | 215,000 | 3,006,000 | 0.28% | ||
| 18 | BLUEBIRD BIO INC COM | 25,000 | 3,019,000 | 0.28% | ||
| 19 | FIVE PRIME THERAPEUTICS INC | 136,000 | 3,108,000 | 0.29% | ||
| 20 | MACROGENICS INC | 116,500 | 3,655,000 | 0.34% | ||
| 21 | TETRAPHASE PHARMACEUTICALS INC COM | 102,500 | 3,756,000 | 0.35% | ||
| 22 | BIOMARIN PHARMACEUTICAL INC | 32,500 | 4,050,000 | 0.38% | ||
| 23 | CASTLIGHT HEALTH INC COM CL B | 525,000 | 4,074,000 | 0.38% | ||
| 24 | KITE PHARMA INCORPORATED | 71,474 | 4,123,000 | 0.39% | ||
| 25 | ASSEMBLY BIOSCIENCES INC | 317,500 | 4,204,000 | 0.39% | ||
| 26 | CHINA CORD BLOOD CORP | 830,000 | 4,241,000 | 0.40% | ||
| 27 | CERNER CORP | 60,000 | 4,396,000 | 0.41% | ||
| 28 | ILLUMINA INC | 24,000 | 4,455,000 | 0.42% | ||
| 29 | JAZZ PHARMACEUTICALS PLC | 26,000 | 4,493,000 | 0.42% | ||
| 30 | PACIRA PHARMACEUTICALS INC | 50,750 | 4,509,000 | 0.42% | ||
| 31 | REGENERON PHARMACEUTICALS | 10,000 | 4,515,000 | 0.42% | ||
| 32 | AERIE PHARMACEUTICALS INC COM | 146,000 | 4,576,000 | 0.43% | ||
| 33 | FIBROGEN INC | 151,300 | 4,748,000 | 0.44% | ||
| 34 | CERULEAN PHARMA INC | 540,000 | 4,865,000 | 0.46% | ||
| 35 | ALLERGAN PLC | 5,000 | 5,150,000 | 0.48% | ||
| 36 | CARDIOME PHARMA CORP | 565,000 | 5,232,000 | 0.49% | ||
| 37 | WELLCARE HEALTH PLANS INC | 60,000 | 5,488,000 | 0.51% | ||
| 38 | ULTRAGENYX PHARMACEUTICAL INC COM | 92,000 | 5,712,000 | 0.53% | ||
| 39 | PUMA BIOTECHNOLOGY | 24,250 | 5,726,000 | 0.54% | ||
| 40 | EPIZYME INC COM | 306,500 | 5,756,000 | 0.54% | ||
| 41 | KYTHERA BIOPHARMACEUTICALS I | 115,000 | 5,767,000 | 0.54% | ||
| 42 | ACHILLION PHARMACEUTICALS IN | 600,000 | 5,916,000 | 0.55% | ||
| 43 | TANDEM DIABETES CARE INC COM | 475,800 | 6,005,000 | 0.56% | ||
| 44 | NOVAVAX INC COM | 730,000 | 6,037,000 | 0.56% | ||
| 45 | COHERUS BIOSCIENCES INC COM | 199,051 | 6,087,000 | 0.57% | ||
| 46 | STERIS PLC | 88,000 | 6,184,000 | 0.58% | ||
| 47 | CONNECTURE INC | 600,000 | 6,210,000 | 0.58% | ||
| 48 | GW PHARMACEUTICALS PLC | 70,000 | 6,379,000 | 0.60% | ||
| 49 | Theravance Biopharma Inc | 374,000 | 6,489,000 | 0.61% | ||
| 50 | Wuxi Pharmatech Inc ADR | 168,000 | 6,515,000 | 0.61% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001184, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
